Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 2/2012

01-03-2012 | Clinical Investigation

Progression detection in different stages of glaucoma: mean deviation versus visual field index

Authors: Jung Woo Cho, Kyung Rim Sung, Sung-Cheol Yun, Jung Hwa Na, Youngrok Lee, Michael S. Kook

Published in: Japanese Journal of Ophthalmology | Issue 2/2012

Login to get access

Abstract

Purpose

We evaluated and compared visual field index (VFI) and mean deviation (MD) capacity in detecting glaucoma progression at different stages.

Methods

Participants were classified as having early-, moderate-, or advanced-stage glaucoma. Trend-based approaches (TA) using linear regression analysis of the VFI and MD (VFI TA, MD TA) over patient age were performed. The rate was determined by both approaches at different stages of glaucoma.

Results

We analyzed 173 eyes of 173 participants (mean follow-up 6.2 years). Glaucoma progressed in 24 eyes (13.9%) as determined by VFI TA and in 21 eyes (12.1%) as determined by MD TA. Agreement between VFI TA and MD TA was moderate to good (κ = 0.617). The rate was −0.29 ± 2.31 dB per year as determined by MD TA and 1.25 ± 4.79% per year as determined by VFI TA. Progression rate according to glaucoma severity was not significantly different among subgroups when assessed by both trend-based approaches.

Conclusion

VFI TA and MD TA performed similarly in measuring different stages of glaucoma progression. However, VFI TA and MD TA did not have agree perfectly in glaucoma progression detection. As glaucomatous changes can be general or localized, we suggest that changes in the MD and VFI should be considered when monitoring glaucoma progression through all stages.
Literature
1.
go back to reference Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–64.PubMedCrossRef Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107:453–64.PubMedCrossRef
2.
go back to reference Heijl A, Lindgren A, Lindgren G. Test–retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130–5.PubMed Heijl A, Lindgren A, Lindgren G. Test–retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130–5.PubMed
3.
go back to reference Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40–8.PubMedCrossRef Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40–8.PubMedCrossRef
4.
go back to reference Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75:184–8.PubMedCrossRef Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75:184–8.PubMedCrossRef
5.
go back to reference Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400–7.PubMed Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400–7.PubMed
6.
go back to reference Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445–55. Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445–55.
7.
go back to reference Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653–62.PubMedCrossRef Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653–62.PubMedCrossRef
8.
go back to reference Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.CrossRef Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.CrossRef
9.
go back to reference Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–53.PubMedCrossRef Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–53.PubMedCrossRef
10.
go back to reference Bebie H. Computerized techniques of visual field analysis. In: Drance SM, Anderson D, editors. Automatic perimetry in glaucoma. Orlando: Grune and Stratton; 1985. p. 147–60. Bebie H. Computerized techniques of visual field analysis. In: Drance SM, Anderson D, editors. Automatic perimetry in glaucoma. Orlando: Grune and Stratton; 1985. p. 147–60.
11.
go back to reference Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1987;49:153–68.CrossRef Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser. 1987;49:153–68.CrossRef
12.
go back to reference Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343–53.PubMedCrossRef Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343–53.PubMedCrossRef
13.
go back to reference Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993. p. 53. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993. p. 53.
14.
go back to reference Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.PubMedCrossRef Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.PubMedCrossRef
15.
go back to reference Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46:4600–6.PubMedCrossRef Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46:4600–6.PubMedCrossRef
16.
go back to reference Casas-Llera P, Rebolleda G, Muñoz-Negrete FJ, Arnalich-Montiel F, Pérez-López M, Fernández-Buenaga R. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol. 2009;93:1576–9.PubMedCrossRef Casas-Llera P, Rebolleda G, Muñoz-Negrete FJ, Arnalich-Montiel F, Pérez-López M, Fernández-Buenaga R. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol. 2009;93:1576–9.PubMedCrossRef
17.
go back to reference Anderson DR, Drance SM, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247–53.PubMedCrossRef Anderson DR, Drance SM, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247–53.PubMedCrossRef
18.
go back to reference Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal–tension glaucoma. Am J Ophthalmol. 2001;131:699–708.PubMedCrossRef Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal–tension glaucoma. Am J Ophthalmol. 2001;131:699–708.PubMedCrossRef
19.
go back to reference Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271–6.PubMedCrossRef Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116:2271–6.PubMedCrossRef
20.
go back to reference Ahrlich K, De Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, et al. Visual field progression difference between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci. 2010;51:1458–63.PubMedCrossRef Ahrlich K, De Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, et al. Visual field progression difference between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci. 2010;51:1458–63.PubMedCrossRef
21.
go back to reference Bengtsson B, Patella VM, Heijl A. Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol. 2009;127:1610–5.PubMedCrossRef Bengtsson B, Patella VM, Heijl A. Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol. 2009;127:1610–5.PubMedCrossRef
Metadata
Title
Progression detection in different stages of glaucoma: mean deviation versus visual field index
Authors
Jung Woo Cho
Kyung Rim Sung
Sung-Cheol Yun
Jung Hwa Na
Youngrok Lee
Michael S. Kook
Publication date
01-03-2012
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 2/2012
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-011-0110-7

Other articles of this Issue 2/2012

Japanese Journal of Ophthalmology 2/2012 Go to the issue